Product Information
MOMETASONE FUROATE 50 MCG SPRY is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $1.5962 per GM under NDC 65162089129. Its NADAC has been published 480 times since Apr 19, 2017.
Strength
50 ug/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162089129
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Last Updated
6/17/2026
Active Ingredients
MOMETASONE FUROATEApproval Type
Generic (ANDA)
FDA Application
ANDA207989On Market Since
4/4/2017
Pharmacological Classes
Price Statistics
The NADAC for MOMETASONE FUROATE 50 MCG SPRY has been published 480 times since Apr 19, 2017, and over the history we have for it it has declined 77.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5962 per GM |
|---|---|
| All-time high | $6.9632 (May 10, 2017) |
| All-time low | $1.5962 (Jun 17, 2026) |
| 52-week high | $1.7874 |
| 52-week low | $1.5962 |
| Median price | $2.2383 |
| Average price | $2.5922 |
| Largest weekly change | +15.0% (Jun 19, 2024) |
| Weeks tracked | 480 |
| Tracking since | Apr 19, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Mometasone market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MOMETASONE FUROATE 50 MCG SPRY?
The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 50 MCG SPRY, manufactured by Amneal Pharmaceuticals LLC, is $1.5962 per GM (NDC 65162089129), effective Jun 24, 2026.
How has the price of MOMETASONE FUROATE 50 MCG SPRY changed over time?
Over the history we have for it, the NADAC for MOMETASONE FUROATE 50 MCG SPRY has declined 77.1%. It has been tracked across 480 weekly CMS publications since Apr 19, 2017.
What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 50 MCG SPRY?
Since Apr 19, 2017, the NADAC for MOMETASONE FUROATE 50 MCG SPRY has ranged from a low of $1.5962 (Jun 17, 2026) to a high of $6.9632 (May 10, 2017), with a median of $2.2383 per GM.
Are there cheaper alternatives to MOMETASONE FUROATE 50 MCG SPRY?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MOMETASONE FUROATE 50 MCG SPRY, so no direct lower-cost alternative is listed.
Who manufactures MOMETASONE FUROATE 50 MCG SPRY?
MOMETASONE FUROATE 50 MCG SPRY (NDC 65162089129) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification